Results 191 to 200 of about 1,836,350 (356)
Aggressive prostate cancer is associated with pericyte dysfunction
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero +11 more
wiley +1 more source
Cinematic Rendering in Anatomy Education: Revolutionizing Visual Learning. [PDF]
Sarangi PK +3 more
europepmc +1 more source
Working together: A dual focus on occupation and anatomy [PDF]
Kelly Fielden, Bel Youngson, D. L. Cox
openalex +1 more source
Anatomy of Fascial Canal of Great Saphenous Vein: An Observational Study
Soumya Khanna +4 more
openalex +2 more sources
Genetic testing in epithelial ovarian cancer includes both germline and tumor‐testing. This approach often duplicates resources. The current prospective study assessed the feasibility of tumor‐first multigene testing by comparing tumor tissue with germline testing of peripheral blood using an 18‐gene NGS panel in 106 patients.
Elisabeth Spenard +12 more
wiley +1 more source
Evaluation of the Concordance of Portal Vein and Biliary Duct Variations: A Retrospective Donor Series. [PDF]
Sönmez Topcu F +4 more
europepmc +1 more source
ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang +8 more
wiley +1 more source

